Medicinal Products

Lenalidomid Accord

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name	Lenalidomid Accord
Active Substance	lenalidomid
Prescription	Medicinal product subject to medical prescription
Type of prescription	ograničeni recept
Distribution	Supply through pharmacies (community)
ATC Code	L04AX04
Marketing status	stavljeno u promet
Shortage status	nema nestašice
Summary of product characteristics (SmPC), labelling and package leaflet (PL)	download
Link to the European Medicines Agency's (EMA) product information	download
Link to the European Commission's (EC) decisions	download
Educational materials for healthcare professionals	Vodic za zdravstvene radnike, verzija 5, travanj 2025 Obrazac za prijavu trudnoće, verzija 3, travanj 2025 Obrazac potvrde bolesnice u reproduktivnoj dobi, verzija 1 travanj 2025 Obrazac potvrde bolesnice koja nije u reproduktivnoj dobi, verzija 1 travanj 2025 Obrazac potvrde muškog bolesnika, verzija 1, travanj 2025
Educational materials for patients / caregivers	Kartica za bolesnika, verzija 4, travanj 2025 Vodic za bolesnice u reproduktivnoj dobi i njihove partnere, verzija 1 travanj 2025 Vodic za bolesnice koje nisu u reproduktvnoj dobi, verzija 1 travanj 2025 Vodic za muške bolesnike, verzija1, travanj 2025

Packaging

Back

For Patients and Public

For Health Care Professionals

For Industry Representatives